Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in reactive arthritis.

Ines Colmegna, Luis R Espinoza

    Current Rheumatology Reports
    |May 28, 2005
    PubMed
    Summary

    Reactive arthritis (ReA) is an immune-mediated disease linked to infection and genetics. Newer anticytokine therapies show promise for severe cases, improving long-term outcomes for patients with human leukocyte antigen-B27-associated ReA.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Umbilical cord mesenchymal stromal cells for respiratory complications of COVID-19 infection (ProTrans): phase II randomized clinical trial.

    Cytotherapy·2026
    Same author

    A novel high-dimensional model for identifying regional DNA methylation QTLs.

    Biostatistics (Oxford, England)·2025
    Same author

    Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 1: Preexisting Inflammatory Arthritides.

    The Journal of rheumatology·2025
    Same author

    Understanding Patient and Physician Perspectives Regarding Innovative Research in Rheumatoid Arthritis.

    The Journal of rheumatology·2025
    Same author

    Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisting Systemic Autoimmune Rheumatic Diseases.

    The Journal of rheumatology·2025
    Same author

    Parvovirus B19-Associated Large-Vessel Vasculitis in an Immunocompromised Patient.

    The Journal of rheumatology·2025

    Area of Science:

    • Rheumatology
    • Immunology
    • Infectious Diseases

    Background:

    • Reactive arthritis (ReA) is a spondyloarthropathy triggered by infection in genetically susceptible individuals.
    • It involves immune-mediated synovitis and potential persistence of non-culturable bacteria or antigens within joints.
    • The long-term prognosis for ReA is poorer than previously thought, with a significant percentage of patients experiencing chronic symptoms.

    Purpose of the Study:

    • To review the latest concepts in the management of human leukocyte antigen-B27-associated Reactive Arthritis.
    • To explore the potential of anticytokine therapy for severe forms of ReA, drawing parallels with other spondyloarthropathies.

    Main Methods:

    • Literature review of recent advancements in understanding and treating Reactive Arthritis.
    • Analysis of existing data on the efficacy of tumor necrosis factor antagonists in related conditions.
    • Focus on urogenital and postenteric triggers of ReA in human leukocyte antigen-B27-positive individuals.

    Main Results:

    • Reactive Arthritis prognosis can involve prolonged joint discomfort, low back pain, and enthesopathies.
    • 15-30% of patients may develop chronic symptoms following acute ReA.
    • Limited therapeutic options have historically been available for severe ReA cases.

    Conclusions:

    • Anticytokine therapy, particularly tumor necrosis factor antagonists, is a potential treatment avenue for severe ReA.
    • Further research into anticytokine efficacy is warranted for human leukocyte antigen-B27-associated Reactive Arthritis.
    • Understanding the latest concepts in ReA management is crucial for improving patient outcomes.

    Related Experiment Videos